申请人:——
公开号:US20030069236A1
公开(公告)日:2003-04-10
The present invention relates to a class of compounds represented by the formula (I)
1
or a pharmaceutical acceptable salt, prodrug or ester thereof, pharmaceutical compositions comprising compounds of the formula (I), and methods of selectively inhibiting or antagonizing &agr;
v
&bgr;
3
integrin.
本发明涉及一类由式(I)表示的化合物,或其药用可接受的盐、前药或酯,包括式(I)化合物的药物组合物,以及选择性抑制或拮抗αvβ3整合素的方法。